Quince Therapeutics Appoints New Name IRulya Therapeutics
Quince Therapeutics Inc. has amended its certificate of incorporation to change its corporate name to IRulya Therapeutics Inc. ahead of an October 9, 2026, effective date. The board unanimously approved the change.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed